
    
      A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study
      to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and
      Multiple Ascending Inhaled Doses of AZD7594 in Healthy Male Volunteers
    
  